Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Guidelines for treating hypertension in the elderly.

J P Emeriau1

  • 1Geriatrics Department, Hôpital Xavier-Arnozan, Pessac, France.

Drugs
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of heart failure in the elderly: recommendations from the French Society of Cardiology (SFC) and the French Society of Gerontology and Geriatrics (SFGG).

The journal of nutrition, health & aging·2006
Same author

Early changes in isokinetic lower limb muscle strength in recovering geriatric subjects on the basis of nutritional status.

The journal of nutrition, health & aging·2005
Same author

[Recommendations for the diagnosis and management of cardic failure in the elderly subject].

Archives des maladies du coeur et des vaisseaux·2004
Same author

Nutritional strategy in the management of heart failure in adults.

American journal of cardiovascular drugs : drugs, devices, and other interventions·2004
Same author

[Incidence, risk factors and adequation of early readmission among the elderly].

Revue d'epidemiologie et de sante publique·2002
Same author

Nutritional status of healthy elderly persons living in Dordogne, France, and relation with mortality and cognitive or functional decline.

European journal of clinical nutrition·2002
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Hypertension affects one-third of older adults and is a major cardiovascular risk. Effective treatment reduces risks of stroke and heart attack, but requires careful monitoring for side effects in the elderly.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Hypertension prevalence increases significantly with age, affecting approximately one-third of the elderly population.
  • Established evidence confirms hypertension as a critical cardiovascular risk factor in older adults, linked to stroke and myocardial infarction incidence.

Purpose of the Study:

  • To highlight the importance of effective hypertension management in the elderly.
  • To underscore the need for careful consideration of age-specific side effects in antihypertensive treatment.

Main Methods:

  • Review of epidemiological data on hypertension in aging populations.
  • Analysis of clinical outcomes associated with hypertension and its treatment in the elderly.

Main Results:

Related Experiment Videos

  • Effective antihypertensive treatment demonstrably reduces the risk of major cardiovascular events, including stroke and myocardial infarction.
  • Antihypertensive therapies can present numerous secondary effects, necessitating tailored management strategies for elderly patients.

Conclusions:

  • Managing hypertension in the elderly is crucial for mitigating cardiovascular morbidity and mortality.
  • Prescription and monitoring of antihypertensive medications must account for age-related physiological changes and potential adverse effects.